J Dawn Abbott

Summary

Affiliation: Rhode Island Hospital
Country: USA

Publications

  1. pmc Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program
    R Michael Kirchner
    Department of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI 02903, USA
    Vasc Health Risk Manag 5:1089-97. 2009
  2. pmc Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital, Providence, RI 02903, USA
    Am Heart J 164:585-590.e4. 2012
  3. ncbi request reprint Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry
    J Dawn Abbott
    Department of Cardiology, Rhode Island Hospital, Providence, Rhode Island, USA
    J Am Coll Cardiol 50:2029-36. 2007
  4. doi request reprint Direct stenting compared to balloon predilation in drug-eluting stents: one-year outcomes from the DEScover Registry
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital, Brown University, Providence, Rhode Island 02903, USA
    Catheter Cardiovasc Interv 79:84-9. 2012
  5. ncbi request reprint Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital, Brown University, Providence, Rhode Island, USA
    Am J Cardiol 100:190-5. 2007
  6. ncbi request reprint Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry)
    J Dawn Abbott
    Department of Cardiology, Rhode Island Hospital, Providence, Rhode Island, USA
    Am J Cardiol 99:626-31. 2007
  7. ncbi request reprint Lessons learned in the drug-eluting stent era
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital and Brown Medical School, Providence, RI, USA
    Am Heart Hosp J 5:169-72. 2007
  8. doi request reprint Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
    Mary Grogan
    Department of Medicine, Rhode Island Hospital, Providence, Rhode Island 02903, USA
    Diabetes Educ 36:774-83. 2010
  9. pmc Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry)
    Shailja V Parikh
    Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern, Dallas, Texas, USA
    Am J Cardiol 107:959-64. 2011
  10. ncbi request reprint Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry
    David O Williams
    Division of Cardiology, Department of Medicine Rhode Island Hospital, Medical School, Brown University, Providence, RI 02903, USA
    Circulation 114:2154-62. 2006

Detail Information

Publications27

  1. pmc Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program
    R Michael Kirchner
    Department of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI 02903, USA
    Vasc Health Risk Manag 5:1089-97. 2009
    ..The implications of the results in terms of interventional practice will be discussed...
  2. pmc Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital, Providence, RI 02903, USA
    Am Heart J 164:585-590.e4. 2012
    ..The risks associated with an abnormal ankle-brachial index (ABI) in patients with type 2 diabetes and stable coronary artery disease have not been well described with respect to thresholds and types of cardiovascular events...
  3. ncbi request reprint Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry
    J Dawn Abbott
    Department of Cardiology, Rhode Island Hospital, Providence, Rhode Island, USA
    J Am Coll Cardiol 50:2029-36. 2007
    ..We investigated the effectiveness and safety of drug-eluting stents (DES) as used in routine clinical practice...
  4. doi request reprint Direct stenting compared to balloon predilation in drug-eluting stents: one-year outcomes from the DEScover Registry
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital, Brown University, Providence, Rhode Island 02903, USA
    Catheter Cardiovasc Interv 79:84-9. 2012
    ..We sought to examine the determinants and outcomes of direct stenting (DS) compared to predilation with drug-eluting stents (DES)...
  5. ncbi request reprint Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital, Brown University, Providence, Rhode Island, USA
    Am J Cardiol 100:190-5. 2007
    ..At 1 year, associated co-morbidities were strongly associated with death and MI, whereas only angiographic characteristics predicted the need for repeat revascularization...
  6. ncbi request reprint Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry)
    J Dawn Abbott
    Department of Cardiology, Rhode Island Hospital, Providence, Rhode Island, USA
    Am J Cardiol 99:626-31. 2007
    ..01) and men (relative risk 0.68, 95% confidence interval 0.51 to 0.91, p = 0.001). In conclusion, the widespread use of DESs is safe and has decreased clinically driven revascularization compared with BMSs equally in women and men...
  7. ncbi request reprint Lessons learned in the drug-eluting stent era
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital and Brown Medical School, Providence, RI, USA
    Am Heart Hosp J 5:169-72. 2007
  8. doi request reprint Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
    Mary Grogan
    Department of Medicine, Rhode Island Hospital, Providence, Rhode Island 02903, USA
    Diabetes Educ 36:774-83. 2010
    ..The purpose of this study was to examine measures of chronic disease severity and treatment according to insurance status in a clinical trial setting...
  9. pmc Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry)
    Shailja V Parikh
    Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern, Dallas, Texas, USA
    Am J Cardiol 107:959-64. 2011
    ..29 to 0.73, p = 0.001). In conclusion, despite significant improvements in medical therapy and a decrease in repeat revascularization over time, patients with PAD who undergo PCI have a persistent high rate of death and MI...
  10. ncbi request reprint Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry
    David O Williams
    Division of Cardiology, Department of Medicine Rhode Island Hospital, Medical School, Brown University, Providence, RI 02903, USA
    Circulation 114:2154-62. 2006
    ..The DEScover Registry was designed to characterize patients selected for drug-eluting stents (DES) in routine clinical practice and their outcomes in the United States...
  11. doi request reprint Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry)
    Joshua Leitner
    Division of Cardiology, Rhode Island Hospital, Brown University, Providence, USA
    Am J Cardiol 109:466-70. 2012
    ..25, confidence interval 0.09 to 0.67, p = 0.006). In conclusion, status after CABG rather than PLM location increases the risk of repeat revascularization with PCI in DES-treated patients...
  12. pmc Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation
    Hazem Al Muradi
    Division of Cardiology, Rhode Island Hospital, Brown University, 593 Eddy St, Providence, RI 02903, USA
    Cardiovasc Revasc Med 13:311-5. 2012
    ..We sought to examine the predictors and presentations of patients with clinically driven TVR after DES...
  13. ncbi request reprint Recent trends in the percutaneous treatment of chronic total coronary occlusions
    J Dawn Abbott
    Division of Cardiology, Rhode Island Hospital, Brown University, Providence, Rhode Island, USA
    Am J Cardiol 97:1691-6. 2006
    ....
  14. doi request reprint Trends in major entry site complications from percutaneous coronary intervention (from the Dynamic Registry)
    Kristal Young
    Brown University Medical School, Department of Medicine, Rhode Island Hospital, Providence, Rhode Island
    Am J Cardiol 113:626-30. 2014
    ..001) were low and decreased with time. The trend in less risk for MES in later time periods remained after adjustment. In conclusion, MES has decreased over time; however, opportunity for bleeding avoidance strategies still exists...
  15. ncbi request reprint Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus
    Andrew M Freeman
    Brown University, Rhode Island Hospital, Providence, Rhode Island 02903, USA
    J Interv Cardiol 19:475-82. 2006
    ..A combination of the use of stents and an increase in adjunctive medical therapy are likely responsible for the observed improvements in outcomes in contemporary PCI...
  16. doi request reprint Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry
    Elizabeth M Holper
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Am Heart J 161:397-403.e1. 2011
    ..Patients with diabetes mellitus (DM) are at higher risk for adverse outcomes following percutaneous coronary intervention (PCI)...
  17. pmc The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
    Premranjan P Singh
    Ocala and Munroe Regional Medical Center, Ocala, Florida, USA
    Diabetes Care 34:464-7. 2011
    ..To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD)...
  18. ncbi request reprint Impact of coronary collaterals on outcome following percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)
    J Dawn Abbott
    Division of Cardiology, Brown University, Rhode Island Hospital, Providence, Rhode Island, USA
    Am J Cardiol 96:676-80. 2005
    ....
  19. doi request reprint Value of cardiovascular magnetic resonance in suspected cardiac amyloidosis
    Antonio B Fernandez
    Department of Medicine, Division of Cardiology, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, USA
    J Cardiovasc Med (Hagerstown) 13:590-2. 2012
    ..We describe a case demonstrating the characteristic pattern of amyloid by cardiovascular magnetic resonance and how this imaging modality can aid in the diagnosis...
  20. ncbi request reprint Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury
    J Dawn Abbott
    Department of Cardiology, Yale University Medical School, New Haven, Conn, USA
    Circulation 110:3300-5. 2004
    ..The mechanisms determining BMDC recruitment to the heart remain unclear. We investigated the role of stromal cell-derived factor-1alpha (SDF-1) in this process...
  21. pmc A comparison of bare-metal and drug-eluting stents for off-label indications
    Oscar C Marroquin
    Cardiovascular Institute, University of Pittsburgh, Pittsburgh, USA
    N Engl J Med 358:342-52. 2008
    ..Recent reports suggest that off-label use of drug-eluting stents is associated with an increased incidence of adverse events. Whether the use of bare-metal stents would yield different results is unknown...
  22. ncbi request reprint Et tu, bare metal stent?
    David O Williams
    Circulation 116:2363-5. 2007
  23. ncbi request reprint Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes
    Ruchira Glaser
    University of Pennsylvania, Philadelphia, USA
    Am J Cardiol 98:1446-50. 2006
    ..05, p = 0.5). In conclusion, women undergoing PCI for NSTACS have a higher risk of major adverse cardiac events than men or women undergoing PCI for stable angina...
  24. ncbi request reprint Treatment of a left internal mammary artery to pulmonary artery fistula with polytetrafluoroethylene covered stents
    J Dawn Abbott
    Department of Internal Medicine, Yale University School of Medicine, Section of Cardiovascular Medicine, New Haven, CT 06520 8017, USA
    Cardiovasc Intervent Radiol 27:74-6. 2004
    ..We describe a case of left IMA-to-PA fistula treated with balloon expandable coronary polytetrafluoroethylene (PTFE) graft stents and review previously reported cases of this entity...
  25. ncbi request reprint What to do with patients receiving long-term clopidogrel: reload or relax?
    David O Williams
    Circulation 118:1219-22. 2008
  26. ncbi request reprint Bifurcation intervention: is it crush time yet?
    David O Williams
    J Am Coll Cardiol 46:621-4. 2005